Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach

Circulation(2024)10.1161/circulationaha.124.069728Source: DataRank Database

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach is a research paper published in Circulation (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

nct doi pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.47)OA: hybridTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Pardeep Kumar ORCID,Yogendra Padwad ORCID,Farouc A. Jaffer ORCID,Guy L. Reed ORCID,Satish Singh ORCID

Live enrichment

PubMed:39250537 PMC:PMC11433585 OpenAlex:https://openalex.org/W4402351018

NHLBI NIH HHS

Grant: R41 HL092750

NHLBI NIH HHS

Grant: R42 HL092750

NHLBI NIH HHS

Grant: R44 HL092750

NHLBI NIH HHS

Grant: R44 HL158376

FWCI

3.47

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1161/circulationaha.124.069728

publisherhttps://doi.org/10.1161/circulationaha.124.069728

publisherhttps://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.124.069728

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39250537

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11433585/

Fields of Study

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsBlood properties and coagulation

MeSH Terms

AnimalsFibrinolysisFibrinolytic AgentsHumansThrombolytic TherapyPlasminogen Activator Inhibitor 1Venous Thromboembolism

Keywords

FibrinolysisMedicinePulmonary embolismVenous thrombosisFibrinolytic agentFibrinThrombosisPlasminogen activatorIntensive care medicineTissue plasminogen activatorCardiologyInternal medicineImmunologyPlasminogenPlasminogen activator inhibitor-1Thrombolytic therapyVenous ThromboembolismAlpha-2-antiplasmin

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)